AI-Driven mRNA Therapeutics Market
完整報告名稱與涵蓋範圍
AI-Driven mRNA Therapeutics Market Size, Share & Trends Analysis Distribution by Application (Prophylactic Vaccines, Therapeutic Vaccines, Protein Replacement Therapies, Gene Editing Support), Therapeutic Area (Infectious Diseases, Oncology, Rare Genetic Diseases, Cardiovascular & Metabolic Disorders), Technology Type (Sequence Optimization, Delivery Systems, Predictive Modeling, Manufacturing Optimization), End-User (Hospitals & Clinics, Research Organizations, Pharmaceutical Companies) and Segment Forecasts, 2025-2034
報告摘要
A CAGR of 24.7% is forecasted for the global AI-Driven mRNA Therapeutics Market over the assessment period of 2025 through 2034.
AI-Driven mRNA Therapeutics covers The AI-based mRNA therapeutics market represents a fast-growing sector in biotech and pharma, utilizing AI to speed up the development and efficacy of mRNA-based treatments. Rapid advancements and evolving end-user preferences are reshaping how technology and communications entities approach this space.
The market's upward path is driven by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in technology and communications.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI-Driven mRNA Therapeutics Market Snapshot
Chapter 4. Global AI-Driven mRNA Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on AI-Driven mRNA Therapeutics Market Industry Trends
4.10. Global AI-Driven mRNA Therapeutics Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. AI-Driven mRNA Therapeutics Market Segmentation 1: By Application, Estimates & Trend Analysis
5.1. Market Share by Application, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
5.2.1. Prophylactic Vaccines
5.2.2. Therapeutic Vaccines
5.2.3. Protein Replacement Therapies
5.2.4. Gene Editing Support
Chapter 6. AI-Driven mRNA Therapeutics Market Segmentation 2: By Therapeutic Area, Estimates & Trend Analysis
6.1. Market Share by Therapeutic Area, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Therapeutic Area:
6.2.1. Infectious Diseases
6.2.2. Oncology
6.2.3. Rare Genetic Diseases
6.2.4. Cardiovascular & Metabolic Disorders
Chapter 7. AI-Driven mRNA Therapeutics Market Segmentation 3: By Technology Type, Estimates & Trend Analysis
7.1. Market Share by Technology Type, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology Type:
7.2.1. Sequence Optimization
7.2.2. Delivery Systems
7.2.3. Predictive Modeling
7.2.4. Manufacturing Optimization
Chapter 8. AI-Driven mRNA Therapeutics Market Segmentation 4: By End-User, Estimates & Trend Analysis
8.1. Market Share by End-User, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:
8.2.1. Hospitals & Clinics
8.2.2. Research Organizations
8.2.3. Pharmaceutical Companies
Chapter 9. AI-Driven mRNA Therapeutics Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global AI-Driven mRNA Therapeutics Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.3. North America AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.2.4. North America AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.2.5. North America AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.3. Europe
9.3.1. Europe AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.3. Europe AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.3.4. Europe AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.3.5. Europe AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.3. Asia Pacific AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.4.4. Asia Pacific AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.4.5. Asia Pacific AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.5. Latin America
9.5.1. Latin America AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.3. Latin America AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.5.4. Latin America AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.5.5. Latin America AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.3. Middle East & Africa AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.6.4. Middle East & Africa AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.6.5. Middle East & Africa AI-Driven mRNA Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Moderna
10.2.1.1. Business Overview
10.2.1.2. Key Application/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. CureVac
10.2.3. Nutcracker Therapeutics
10.2.4. Ethris
10.2.5. Baidu (LinearDesign)
10.2.6. IBM
10.2.7. DeepMind (Alphabet)
10.2.8. Anima Biotech
10.2.9. Translate Bio (Sanofi)
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們